-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Ambrx Biopharma, Inc. quarterly Net Income (Loss) Attributable to Parent history and growth rate from Q3 2022 to Q3 2023.
- Ambrx Biopharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$23M, a 47.7% decline year-over-year.
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)